Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2006-09-21Clinical Trial Update: Study of Improving Insulin Sensitivity by Electroacupuncture Therapy [NA]
Clinical trial evaluating electroacupuncture therapy to improve insulin sensitivity in Type 2 diabetes. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2006-09-13Clinical Trial Update: The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial [Phase 3]
The HOME Trial (Phase 3), a randomized controlled study evaluating the metabolic effects of hyperinsulinaemia in Type 2 Diabetes Mellitus, h…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: The Effects of Two Education Strategies About Insulin on Patient Preferences and Perceptions About Insulin Therapy [Phase 4]
Phase 4 clinical trial comparing two education strategies about insulin and their effects on patient preferences and perceptions of insulin …
-
CLINICAL_TRIALS withdrawal · 2006-09-08Clinical Trial Update: Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina [Phase 4]
A Phase 4 trial comparing rosiglitazone versus gliclazide in adults with type 2 diabetes and angina has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2006-09-04Clinical Trial Update: Effect of Fish Oil on Adiposity and Atherogenic Factors in Type 2 Diabetic Women [NA]
Terminated clinical trial assessing the impact of fish oil on adiposity and atherogenic factors in women with type 2 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2006-09-01Clinical Trial Update: Jikei Optimal Insulin Therapy in Type 2 Diabetes [NA]
A clinical trial by Jikei University evaluating optimal insulin therapy for Type 2 diabetes is ongoing, with the current status not provided…
-
FDA approval · 2006-08-30FDA Approved: ACTOPLUS MET — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Actoplus Met (pioglitazone and metformin hydrochloride) submitted by Takeda Pharmaceuticals Amer…
-
FDA approval · 2006-08-30FDA Approved: ACTOS — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for ACTOS (pioglitazone) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2006-08-29Clinical Trial Update: Efficacy and Safety of ATL-962 in Obese Diabetics [Phase 2]
Phase 2 trial assessing the efficacy and safety of ATL-962 in patients with Type 2 diabetes mellitus and obesity has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Effects of Reiki on Painful Neuropathy and Cardiovascular Risk Factors [Phase 2]
Phase 2 clinical trial evaluating Reiki for painful neuropathy and cardiovascular risk factors in patients with coronary artery disease and …
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Ginkgo Biloba Extract and the Insulin Resistance Syndrome [Phase 1, Phase 2]
A clinical trial evaluated Ginkgo Biloba Extract for insulin resistance in adults with Type 2 Diabetes Mellitus, covering Phase 1 and Phase …
-
CLINICAL_TRIALS trial_result · 2006-08-16Clinical Trial Update: Moderate Alcohol Consumption, Risk of Cardiovascular Disease and Type 2 Diabetes: Influence of Alcohol Oxidation [NA]
A completed clinical trial assessing how moderate alcohol consumption and alcohol oxidation relate to the risks of cardiovascular disease an…
-
FDA approval · 2006-08-15FDA Approved: BROMOCRIPTINE MESYLATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approval of a supplemental application for a generic bromocriptine mesylate product by Mylan Pharmaceuticals Inc.
-
FDA approval · 2006-08-15FDA Approved: GLIMEPIRIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for glimepiride from Dr. Reddy's Laboratories Limited, authorizing a generic version under an ANDA.
-
CLINICAL_TRIALS trial_result · 2006-08-15Clinical Trial Update: Lifestyle Interventions for Long Term Diabetes Control [NA]
An update on a University of Virginia-sponsored clinical trial evaluating lifestyle interventions for long-term control of type 2 diabetes m…
-
CLINICAL_TRIALS trial_result · 2006-08-09Clinical Trial Update: Effect of Chia Seeds (Salvia Hispanica L.) on Glucose Control in Patients With Type 2 Diabetes [Phase 2]
A Phase 2 clinical trial evaluating the effect of chia seeds on glucose control in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-07Clinical Trial Update: Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy [NA]
A completed clinical trial evaluated how losartan affects insulin sensitivity and secretion in individuals with type 2 diabetes and diabetic…
-
CLINICAL_TRIALS trial_result · 2006-07-31Clinical Trial Update: GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 trial evaluating dose-finding, efficacy, and safety of tesaglitazar (AZ 242) in adults with Type 2 diabetes mellitus completed.
-
CLINICAL_TRIALS trial_result · 2006-07-31Clinical Trial Update: Local Registration Trial in China Humalog Mix 50 [Phase 3]
A Phase 3 local registration trial of Humalog Mix 50 for diabetes mellitus type 1 and type 2 in China has completed.
-
FDA approval · 2006-07-28FDA Approved: PIOGLITAZONE AND GLIMEPIRIDE — Original Application (Prasco Laboratories)
FDA approved Pioglitazone and Glimepiride as an original application by Prasco Laboratories. The product is indicated for type 2 diabetes me…
-
CLINICAL_TRIALS trial_result · 2006-07-19Clinical Trial Update: An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes [Phase 2]
Phase 2 trial update evaluating an oral antidiabetic agent for treatment of Type 2 diabetes (non-insulin-dependent).
-
CLINICAL_TRIALS trial_result · 2006-07-14Clinical Trial Update: A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes [Phase 4]
Phase 4 trial comparing calcium channel blockers with Angiotensin II receptor antagonists in patients with hypertension and type 2 diabetes;…
-
CLINICAL_TRIALS trial_result · 2006-06-13Clinical Trial Update: A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients [Phase 4]
A Phase 4 double-blind, randomized study assessing the efficacy and safety of repaglinide for treating Type 2 diabetes; current status is UN…
-
FDA approval · 2006-06-05FDA Approved: METFORMIN HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved an original Abbreviated New Drug Application for metformin hydrochloride tablets, a generic version of metformin. The produ…
-
CLINICAL_TRIALS trial_result · 2006-05-18Clinical Trial Update: Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria [Phase 4]
A Phase 4 trial completed evaluating the optimal dose of irbesartan for renoprotection in adults with type 2 diabetes mellitus and persisten…